Moreover, PRI-724, as a selective inhibitor of CBP/β-catenin interaction, specifically destroys the interaction between β-catenin and CBP and has an encouraging effect in anti-liver fibrosis (Nishikawa et al., 2018). This evidence concerns the gene CREBBP and Hepatic fibrosis.